For South Korean firms, biosimilars are gateway drugs
HONG KONG – Multinational biopharmaceutical companies are looking beyond China and paying more attention to emerging markets in Asia, even as local companies are looking outward from their home markets and using biosimilars as their ladders to climb up to the global market.
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST